Title : Hot Topics in Primary Care: The Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs: Putting the Evidence in Perspective.

Pub. Date : 2017 Apr

PMID : 28375409






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The Vioxx Gastrointestinal Outcomes Research (VIGOR) trial, published in 2000, was the first to raise concerns that NSAIDs (specifically, the COX-2 selective inhibitor rofecoxib) might be associated with a higher risk for cardiovascular (CV) events. rofecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens
2 The Vioxx Gastrointestinal Outcomes Research (VIGOR) trial, published in 2000, was the first to raise concerns that NSAIDs (specifically, the COX-2 selective inhibitor rofecoxib) might be associated with a higher risk for cardiovascular (CV) events. rofecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens